首页> 外文期刊>Addiction biology >Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects
【24h】

Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects

机译:早期和晚期可卡因依赖性受试者对5HT3拮抗剂的局部脑血流反应的差异

获取原文
获取原文并翻译 | 示例
           

摘要

5-hydroxytryptamine 3 (5HT3) receptors are important modulators of mesostriatal dopaminergic transmission and have been implicated in the pathophysiology of cocaine reward, withdrawal and self-administration. In addition, the 5HT3 antagonist ondansetron is effective in treating early-onset, but not late-onset, alcohol-dependent subjects. To explore the role of 5HT3 receptor systems in cocaine addiction using functioning imaging, we administered ondansetron to 23 abstinent, treatment-seeking cocaine-addicted and 22 sex-, age- and race-matched healthy control participants. Differences between early- (first use before 20 years, n = 10) and late-onset (first use after 20 years, n = 10) cocaine-addicted subjects were also assessed. On two separate days, subjects were administered ondansetron (0.15 mg/kg intravenously over 15 minutes) or saline. Regional cerebral blood flow (rCBF) was measured following each infusion with single photon emission computed tomography. No significant rCBF differences between the cocaine-addicted and control participants were observed following ondansetron relative to saline. Early-onset subjects, however, showed increased (P < 0.001) right posterior parahippocampal rCBF following ondansetron. In contrast, late-onset subjects showed decreased rCBF following ondansetron in an overlapping region of the right parahippocampal/ hippocampal gyrus. Early-onset subjects also displayed increased rCBF in the left anterior insula and subthalamic nucleus following ondansetron; late-onset subjects showed decreased rCBF in the right anterior insula. These findings suggest that the age of drug use onset is associated with serotonergic biosignatures in cocaine-addicted subjects. Further clarification of these alterations may guide targeted treatment with serotonergic medications similar to those successfully used in alcohol-dependent patients.
机译:5-羟色胺3(5HT3)受体是中鼻道多巴胺能传递的重要调节剂,并且与可卡因奖赏,戒断和自我给药的病理生理有关。此外,5HT3拮抗剂恩丹西酮可有效治疗早发型而非酒精依赖型受试者。为了使用功能性成像探讨5HT3受体系统在可卡因成瘾中的作用,我们向23名戒断,寻求治疗可卡因的成瘾者和22名性别,年龄和种族匹配的健康对照参与者施用了恩丹西酮。还评估了早期(20年之前首次使用,n = 10)和晚发型(20年之后首次使用,n = 10)可卡因上瘾的受试者之间的差异。在独立的两天中,向受试者施用恩丹西酮(在15分钟内静脉注射0.15 mg / kg)或盐水。每次输注后用单光子发射计算机断层扫描测量局部脑血流量(rCBF)。恩丹西酮组相对于生理盐水后,在可卡因成瘾者和对照参与者之间未观察到明显的rCBF差异。然而,早期发作的受试者在恩丹西酮后显示出右海马后旁rCBF增加(P <0.001)。相比之下,迟发受试者在右西海马/海马回的重叠区域中在恩丹西酮后显示出rCBF降低。早期发作的受试者在恩丹西酮后还显示左前岛和丘脑下核的rCBF增加。迟发性受试者显示右前岛的rCBF降低。这些发现表明,在可卡因成瘾的受试者中,开始使用药物的年龄与血清素能的生物特征有关。对这些改变的进一步阐明可以指导血清素能药物的靶向治疗,类似于在酒精依赖患者中成功使用的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号